Neuroplasticity and cellular therapy in cerebral infarction.
Stroke is the second to third most common cause of death in adults, and more than a third of people who survive a stroke will have severe disability. Therapeutic options currently centre on fibrinolytic treatment, but its limitations restrict use to a small proportion of patients. Although a wide range of neuroprotective substances has been effective in experimental models, they have repeatedly failed in clinical trials because of toxicity or loss of effectiveness. Recent strategies based on neuroplasticity and cellular therapy have shown significant efficacy in improving functional recovery in experimental models, although further study is still necessary to clarify how the brain responds to ischaemic damage and is able to reorganize itself in the long term. Although steps must still be taken to ensure the safety and feasibility of treatments based on neuroplasticity and cellular therapy, neurorepair strategies provide promising future therapeutic options for stroke.
Rodríguez-González
Raquel
R
Clinical Neuroscience Research Laboratory, Division of Vascular Neurology, Department of Neurology, Hospital Clínico Universitario, University of Santiago de Compostela, Santiago de Compostela, Spain.
Hurtado
Olivia
O
Sobrino
Tomás
T
Castillo
José
J
D000818:Animals; D002544:Cerebral Infarction / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D009473:Neuronal Plasticity; D033581:Stem Cell Transplantation; D020521:Stroke / Q000503:physiopathology / Q000628:therapy*